{"transactions":[{"id":969979,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T16:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001055404-25-000004","document":"form4-12152025_041205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000105540425000004/form4-12152025_041205.xml","form_type":"4"}},{"id":1301736,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-16T18:06:19.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.92,"value":43800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.8776 to $2.9836, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":51472,"source":{"system":"sec-edgar","filing":"0001415889-25-001574","document":"form4-01162025_110115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000141588925001574/form4-01162025_110115.xml","form_type":"4"}},{"id":1332967,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:29.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029290","document":"form4-12132024_041215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000141588924029290/form4-12132024_041215.xml","form_type":"4"}},{"id":1693854,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:13:09.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919124000462/doc4.xml","form_type":"4"}},{"id":1709762,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:05:26.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919123058812/doc4.xml","form_type":"4"}},{"id":1737397,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T17:03:12.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":3.906,"value":50778.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":36472,"source":{"system":"sec-edgar","filing":"0001209191-23-055787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919123055787/doc4.xml","form_type":"4"}},{"id":1942129,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-22T16:03:15.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.484,"value":49680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock.  The number of securities reported reflects the reverse split."}],"balance_after":23472,"source":{"system":"sec-edgar","filing":"0001209191-23-020480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919123020480/doc4.xml","form_type":"4"}},{"id":2119464,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T16:16:01.000Z","date":"2022-11-10","kind":"purchase","acquired":true,"shares":100000,"price":0.49,"value":49000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging between $0.47 and $0.52. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":587145,"source":{"system":"sec-edgar","filing":"0001209191-22-056589","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919122056589/doc4.xml","form_type":"4"}},{"id":2187281,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-08-12T17:11:41.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023."}],"balance_after":20500,"derivative":{"exercise_price":0.312,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-22-045651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919122045651/doc4.xml","form_type":"4"}},{"id":2269611,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T16:16:50.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":50000,"price":0.54,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging between $0.51 and $0.56. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":487145,"source":{"system":"sec-edgar","filing":"0001209191-22-029599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919122029599/doc4.xml","form_type":"4"}},{"id":2405689,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T17:17:45.000Z","date":"2022-02-08","kind":"purchase","acquired":true,"shares":50000,"price":0.88,"value":44000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging between $0.87 to $0.90. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":437145,"source":{"system":"sec-edgar","filing":"0001209191-22-008540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919122008540/doc4.xml","form_type":"4"}},{"id":2489345,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T17:08:05.000Z","date":"2021-11-30","kind":"purchase","acquired":true,"shares":12500,"price":1.0159,"value":12698.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a 10b5-1 plan entered into by the reporting person on April 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.98 to $1.03, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001209191-21-067647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919121067647/doc4.xml","form_type":"4"}},{"id":2492729,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T16:05:05.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":50000,"price":1.71,"value":85500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.66 to $1.76. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":387145,"source":{"system":"sec-edgar","filing":"0001209191-21-067118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919121067118/doc4.xml","form_type":"4"}},{"id":2575452,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-09T16:07:00.000Z","date":"2021-09-08","kind":"purchase","acquired":true,"shares":20000,"price":3.31,"value":66200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.28 to $3.35. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":337145,"source":{"system":"sec-edgar","filing":"0001209191-21-055276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919121055276/doc4.xml","form_type":"4"}},{"id":2582900,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-02T18:30:30.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":56819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards that vested in full on August 31, 2021"}],"balance_after":317145,"source":{"system":"sec-edgar","filing":"0001209191-21-054553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919121054553/doc4.xml","form_type":"4"}},{"id":2589849,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-26T17:04:36.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":12500,"price":1.6,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-21-053498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919121053498/doc4.xml","form_type":"4"}},{"id":2629494,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-07-20T17:06:13.000Z","date":"2021-07-19","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022."}],"balance_after":20500,"derivative":{"exercise_price":2.75,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-21-047411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919121047411/doc4.xml","form_type":"4"}},{"id":2693933,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T17:18:50.000Z","date":"2021-05-26","kind":"purchase","acquired":true,"shares":12500,"price":3.5966,"value":44957.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.48 to $3.6950, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001209191-21-036302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919121036302/doc4.xml","form_type":"4"}},{"id":2717855,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T16:50:36.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":20000,"price":4.18,"value":83600.0,"ownership":{"direct":true},"balance_after":260326,"source":{"system":"sec-edgar","filing":"0001209191-21-032077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919121032077/doc4.xml","form_type":"4"}},{"id":2787054,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T16:38:35.000Z","date":"2021-03-15","kind":"purchase","acquired":true,"shares":12500,"price":7.405,"value":92562.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.39 to $7.42, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-020834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919121020834/doc4.xml","form_type":"4"}},{"id":2955501,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T16:31:22.000Z","date":"2020-12-03","kind":"purchase","acquired":true,"shares":50000,"price":1.7085,"value":85425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.69 to $1.735, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-061946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919120061946/doc4.xml","form_type":"4"}},{"id":2986892,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-11-10T16:05:44.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":122605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":122605,"derivative":{"exercise_price":0.82,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":122605},"source":{"system":"sec-edgar","filing":"0001493152-20-020925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000149315220020925/ownership.xml","form_type":"4"}},{"id":3032514,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-09-14T16:39:36.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.46,"expiration_date":"2030-09-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-050292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919120050292/doc4.xml","form_type":"4"}},{"id":3040405,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-03T16:25:23.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":38986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards that vested in full on September 1, 2020"}],"balance_after":240326,"source":{"system":"sec-edgar","filing":"0001209191-20-049400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919120049400/doc4.xml","form_type":"4"}},{"id":3145899,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-05-18T10:00:50.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":100000,"price":0.7305,"value":73050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.7248 to $0.7399, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001493152-20-009278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000149315220009278/ownership.xml","form_type":"4"}},{"id":3366470,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-11-19T10:00:11.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":100000,"price":1.0553,"value":105530.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001493152-19-017920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000149315219017920/ownership.xml","form_type":"4"}},{"id":3380657,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-11-05T16:05:13.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":107416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":107416,"derivative":{"exercise_price":0.912,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":107416},"source":{"system":"sec-edgar","filing":"0001493152-19-016458","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000149315219016458/ownership.xml","form_type":"4"}},{"id":3422677,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T16:15:24.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":25000,"price":9.82,"value":245500.0,"ownership":{"direct":true},"balance_after":201340,"source":{"system":"sec-edgar","filing":"0001209191-19-048496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919119048496/doc4.xml","form_type":"4"}},{"id":3433436,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-08-20T10:02:46.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":100000,"price":0.7185,"value":71850.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000905718-19-000714","document":"matinas_fm4aug162019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000090571819000714/matinas_fm4aug162019.xml","form_type":"4"}},{"id":3458299,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T16:25:11.000Z","date":"2019-07-19","kind":"grant","acquired":true,"shares":33445,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":176340,"source":{"system":"sec-edgar","filing":"0001209191-19-042872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919119042872/doc4.xml","form_type":"4"}},{"id":3518939,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-05-20T18:39:49.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":100000,"price":0.9525,"value":95250.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-19-007948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000149315219007948/ownership.xml","form_type":"4"}},{"id":3534586,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T16:21:13.000Z","date":"2019-05-08","kind":"purchase","acquired":true,"shares":25000,"price":7.32,"value":183000.0,"ownership":{"direct":true},"balance_after":142895,"source":{"system":"sec-edgar","filing":"0001209191-19-028478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919119028478/doc4.xml","form_type":"4"}},{"id":3662205,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-13T16:30:12.000Z","date":"2019-02-12","kind":"purchase","acquired":true,"shares":25000,"price":8.93,"value":223250.0,"ownership":{"direct":true},"balance_after":117895,"source":{"system":"sec-edgar","filing":"0001209191-19-009634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919119009634/doc4.xml","form_type":"4"}},{"id":3730184,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-17T11:14:37.000Z","date":"2018-12-13","kind":"purchase","acquired":true,"shares":25000,"price":5.1,"value":127500.0,"ownership":{"direct":true},"balance_after":92895,"source":{"system":"sec-edgar","filing":"0001209191-18-062863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919118062863/doc4.xml","form_type":"4"}},{"id":3774549,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T08:15:25.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":128299,"derivative":{"exercise_price":0.74,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000905","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000090571818000905/ownership.xml","form_type":"4"}},{"id":3823918,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-09-06T08:20:34.000Z","date":"2018-09-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 36 months commencing on October 5, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":150000,"derivative":{"exercise_price":0.44,"expiration_date":"2028-09-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000905718-18-000782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000090571818000782/ownership.xml","form_type":"4"}},{"id":3828254,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-04T16:19:30.000Z","date":"2018-08-31","kind":"purchase","acquired":true,"shares":25000,"price":5.34,"value":133500.0,"ownership":{"direct":true},"balance_after":67895,"source":{"system":"sec-edgar","filing":"0001209191-18-049182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919118049182/doc4.xml","form_type":"4"}},{"id":3863291,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-23T18:19:14.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":16195,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42895,"source":{"system":"sec-edgar","filing":"0001209191-18-043640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919118043640/doc4.xml","form_type":"4"}},{"id":3936452,"issuer":{"id":122287,"kind":"organization","name":"LANNETT CO INC","symbol":"LCI"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T16:12:11.000Z","date":"2018-05-11","kind":"purchase","acquired":true,"shares":25000,"price":15.13,"value":378250.0,"ownership":{"direct":true},"balance_after":26700,"source":{"system":"sec-edgar","filing":"0001209191-18-029819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/57725/000120919118029819/doc4.xml","form_type":"4"}},{"id":4138237,"issuer":{"id":171237,"kind":"organization","name":"PharMerica CORP","symbol":"PMC"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2017-12-08T17:16:47.000Z","date":"2017-12-07","kind":"disposition_to_issuer","acquired":false,"shares":29570,"price":29.25,"value":864922.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the \"Merger Agreement\"), by and among PharMerica Corporation (the \"Company\"), Phoenix Parent Holdings Inc., a Delaware corporation (\"Parent\"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time (\"Effective Time\") of the merger, Merger Sub will merge with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) each share of the Company's common stock, par value $0.01 per share (\"Company Common Stock\") owned by the reporting person was converted into the right to receive $29.25 in cash without interest (the \"Merger Consideration\") and (ii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, multiplied by (y) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-064772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919117064772/doc4.xml","form_type":"4"}},{"id":4279445,"issuer":{"id":171237,"kind":"organization","name":"PharMerica CORP","symbol":"PMC"},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2017-06-16T16:43:50.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":4817,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29570,"source":{"system":"sec-edgar","filing":"0001209191-17-040543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919117040543/doc4.xml","form_type":"4"}},{"id":4346838,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-24T21:06:18.000Z","date":"2017-04-20","kind":"grant","acquired":true,"shares":19857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":58278,"source":{"system":"sec-edgar","filing":"0001179110-17-006171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017006171/edgar.xml","form_type":"4"}},{"id":4573592,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-27T22:31:11.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":38421,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38421,"source":{"system":"sec-edgar","filing":"0001179110-16-030971","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911016030971/edgar.xml","form_type":"4"}}]}